BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.115
+0.015 (1.36%)
Jan 28, 2026, 1:14 PM EST - Market open

BioRestorative Therapies Revenue

BioRestorative Therapies had revenue of $11.80K in the quarter ending September 30, 2025, a decrease of -94.95%. This brings the company's revenue in the last twelve months to $383.40K, up 1.70% year-over-year. In the year 2024, BioRestorative Therapies had annual revenue of $401.00K with 175.03% growth.

Revenue (ttm)
$383.40K
Revenue Growth
+1.70%
P/S Ratio
24.64
Revenue / Employee
$34,855
Employees
11
Market Cap
9.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024401.00K255.20K175.03%
Dec 31, 2023145.80K26.00K21.70%
Dec 31, 2022119.80K73.80K160.43%
Dec 31, 202146.00K-31.00K-40.26%
Dec 31, 202077.00K-53.00K-40.77%
Dec 31, 2019130.00K19.00K17.12%
Dec 31, 2018111.00K30.00K37.04%
Dec 31, 201781.00K44.65K122.80%
Dec 31, 201636.36K-592.56K-94.22%
Dec 31, 2015628.92K212.92K51.18%
Dec 31, 2014416.00K414.32K24,661.67%
Dec 31, 20131.68K-13.91K-89.22%
Dec 31, 201215.59K--
Dec 31, 2011---
Dec 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evogene8.02M
Immuron4.78M
SeaStar Medical Holding881.00K
CytoMed Therapeutics573.19K
Pulmatrix3.00K
Ernexa Therapeutics1,000.00
Revenue Rankings